PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35114189-0 2022 Nigericin exerts anticancer effects through inhibition of the SRC/STAT3/BCL-2 in osteosarcoma. Nigericin 0-9 SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens 62-65 35114189-7 2022 Furthermore, bioinformatics predicted that Nigericin exerts anticancer effects through inhibiting SRC/STAT3 signaling pathway in osteosarcoma. Nigericin 43-52 SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens 98-101 35114189-10 2022 In order to further elucidate the inhibitory effect of nigericin on SRC / STAT3 / Bcl-2 signal transduction mechanism, we established human osteosarcoma cancer cells stably expressing STAT3. Nigericin 55-64 SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens 68-71 9124524-4 1997 Sodium propionate addition, NH4Cl prepulse, and nigericin addition, maneuvers that decrease intracellular pH in the absence of changes in extracellular pH, activated c-Src. Nigericin 48-57 SRC proto-oncogene, non-receptor tyrosine kinase Homo sapiens 166-171